Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
GNI Group, headquartered in Japan, is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines. The company focuses on treating inflammatory diseases and fibrosis through the advancement of novel therapeutic agents.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
GNI Group is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
GNI Group last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at 2.54 JPY.
GNI Group has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.